project id: TCGA-LUAD; case submitter id: TCGA-L9-A50W; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; rna integrity number: 8.1; age at index: 75; days to birth: -27414; days to death: 442; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1937; age at diagnosis: 27414; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 266.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.0410958904109588; pack years smoked: 19.0; years smoked: 19.0; is ffpe: false; composition: Not Reported; days to collection: 205; days to sample procurement: 0; initial weight: 240.0; portion submitter id: TCGA-L9-A50W-01A-12; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 100.0;